rs4655683
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
|
30552173 |
2019 |
rs11209026
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The association to PsA was observed in the presence of polymorphisms: TNF-238 G > A (rs361525), -308 G > A (rs1800629), and -857 C > T (rs1799724); IL12B C > G (rs6887695) and A > C (rs3212227); IL23A A > G (rs2066808) and IL23R G > A (rs11209026).
|
30584776 |
2019 |
rs11209026
|
|
|
0.040 |
GeneticVariation |
BEFREE |
For rs11209026, the odds ratios (ORs) of minor alleles for psoriasis and PsA were 0.616 [95 % confidence interval (CI) 0.563-0.674] and 0.630 (95 % CI 0.524-0.757), respectively.
|
22706445 |
2012 |
rs11209026
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Significant associations between Arg381Gln SNP and haplotypes encoding this variant were noted in PsA.
|
19040306 |
2009 |
rs11209026
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Two IL23R SNPs (rs7530511 and rs11209026) and 2 IL12B SNPs (rs3212227 and rs6887695) were genotyped in DNA samples from 520 white patients with PsA and 2,260 control subjects, all of whom resided in the UK.
|
19035472 |
2008 |
rs7530511
|
|
|
0.030 |
GeneticVariation |
BEFREE |
For rs7530511, the pooled ORs were 0.820 (95 % CI 0.764-0.879) for psoriasis and 0.875 (95 % CI 0.766-1.000) for PsA; for rs2201841 the OR was 1.121 (95 % CI 1.031-1.219) for psoriasis.
|
22706445 |
2012 |
rs7530511
|
|
|
0.030 |
GeneticVariation |
BEFREE |
A 2-marker haplotype from SNP rs7530511 and rs11209026 was associated with PsA (p=0.011).
|
19040306 |
2009 |
rs7530511
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Two IL23R SNPs (rs7530511 and rs11209026) and 2 IL12B SNPs (rs3212227 and rs6887695) were genotyped in DNA samples from 520 white patients with PsA and 2,260 control subjects, all of whom resided in the UK.
|
19035472 |
2008 |
rs2201841
|
|
|
0.020 |
GeneticVariation |
BEFREE |
IL-23R gene polymorphism rs2201841 is associated with psoriatic arthritis.
|
24910145 |
2014 |
rs2201841
|
|
|
0.020 |
GeneticVariation |
BEFREE |
For rs7530511, the pooled ORs were 0.820 (95 % CI 0.764-0.879) for psoriasis and 0.875 (95 % CI 0.766-1.000) for PsA; for rs2201841 the OR was 1.121 (95 % CI 1.031-1.219) for psoriasis.
|
22706445 |
2012 |